Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is included in first-line antiretroviral treatment (ART) for adolescents living with HIV (ALWH). Associated toxicities remain a concern. OBJECTIVE: We evaluated bone and renal safety outcomes in virologically suppressed South African ALWH after switchi...

Descripción completa

Detalles Bibliográficos
Autores principales: Braithwaite, Kate, McPherson, Tristan D., Shen, Yanhan, Arpadi, Stephen, Shiau, Stephanie, Sorour, Gillian, Technau, Karl-Günter, Yin, Michael T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424762/
https://www.ncbi.nlm.nih.gov/pubmed/34522425
http://dx.doi.org/10.4102/sajhivmed.v22i1.1243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424762/
https://www.ncbi.nlm.nih.gov/pubmed/34522425
http://dx.doi.org/10.4102/sajhivmed.v22i1.1243

Ejemplares similares